With so much tilting voters against change, democratic reason is the loser, says Solly Moeng.
True grit is a reliable predictor of who will achieve success in life, says Ian Mann.
The system sucks and it’s being used far too often as an excuse, says Mandi Smallhorne.
Mediclinic International has announced 7% revenue growth for the year to end-March, thanks to stable margins at 20.3% driving strong underlying earnings growth.
Ascendis Health has announced acquisitions of two European health and care businesses, Remedica and Scitec.
German drugs and chemicals giant Bayer has offered $62bn for US agriculture group Monsanto as it seeks to create the world's biggest supplier of seeds, pesticides and genetically-modified crops.
Shares in Bayer have slid by 7% at the start of trade after the chemicals and pharmaceuticals giant said it was in merger talks with Monsanto.
The Netcare hospital group has reported an 11% rise in half-year profit as a strong showing at home offset weak demand in the United Kingdom.
Abraaj will spend up to $500m in start-up capital for a mid-tier hospital business in Africa, tapping into demand from the continent's emerging middle classes.
At his annual meeting, Warren Buffett has defended his daily intake of 700 calories Cherry Coke with the sort of folksy logic that has made him so appealing.
Novartis has said first-quarter earnings have fallen 12% after the company’s best-selling cancer medicine Gleevec faced generic competition in the US.
The Independent Community Pharmacy Association wants the Competition Commission to "level the playing field" in what it alleges to be counter competitive practices by the Clicks Group.
Ascendis Health has received Competition Commission approval to proceed with the acquisition of pharmaceutical business Akacia Healthcare.
US drug firm Valeant has suffered its worst day ever amid a $600m typo in a press release which caused its leading investor to lose $1.2bn in a 51% stock drop.
A look at why it's important to insure against certain events that may put you out of business.
Outcome-based investing is about dialogue and managing client expectation.
Making collection of old debt illegal has caused a big drop in civil summonses.
SA, like China, should implement changes to make it less dependent on commodities.
Gari Dombo of Alexander Forbes gives insurance tips for property rentals.
An expert says Zuma's multi-million fund for entrepreneurs is an unrealistic dream.
A Fin24 user tells how he escaped the debt trap without even needing a debt counsellor.
As PW's lack of reform led to sanctions, will Zuma’s inaction plunge SA into junk status?
A judgment of the Supreme Court of Appea raises the question whether this now overrides your scheme’s benefit schedule?
The success of Ascendis Health lies in its strategy of diversification, says CEO Dr Karsten Wellner at the announcement of interim results.
Microsoft and Facebook are building a new sub-sea Internet cable that will cross the Atlantic Ocean to carry customers' data between North America and Southern Europe
Previous results ·
Suggest a vote
Get your financial questions answered.
News delivered really simply.
Easy-to-use personal finance tools.
You choose what you want.
Lost? Confused? Problems? Let us help you.